Adam Hacker
Keine laufenden Positionen mehr
Profil
Adam Hacker worked as VP, Head-Vaccines & Global Regulatory Affairs at Johnson & Johnson from 2008 to 2018.
Prior to that, he was Head-Oncology & Immunology at Biogen Idec Ltd.
from 2004 to 2008 and Regulatory Project Manager at GlaxoSmithKline UK Ltd.
from 1998 to 2002.
He also worked as a Regulatory Project Manager at GE Healthcare UK Ltd.
Dr. Hacker holds an undergraduate degree from the University of Oxford and a doctorate from The National Institute For Medical Research.
Ehemalige bekannte Positionen von Adam Hacker
| Unternehmen | Position | Ende |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | General Counsel | 01.01.2021 |
| JOHNSON & JOHNSON | General Counsel | 01.01.2018 |
Biogen Idec Ltd.
 Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Corporate Officer/Principal | 01.06.2008 |
GlaxoSmithKline UK Ltd.
 GlaxoSmithKline UK Ltd. Medical DistributorsDistribution Services Part of GSK Plc, GlaxoSmithKline UK Ltd. is a biopharma company that unites science, technology, and talent to get ahead of disease together. The company is based in Middlesex, UK and is focused on discovering and developing new products. The British company's portfolio includes vaccines, specialty, and general medicines. | Corporate Officer/Principal | 01.06.2002 |
GE Healthcare UK Ltd.
 GE Healthcare UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Danaher Corp., Global Life Sciences Solutions Operations UK Ltd. is a company that engages in the manufacture of basic pharmaceutical products. The company is based in Little Chalfont, UK. Global Life Sciences Solutions Operations was founded in 1997. | Corporate Officer/Principal | - |
Ausbildung von Adam Hacker
| University of Oxford | Undergraduate Degree |
| The National Institute For Medical Research | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Biogen Idec Ltd.
Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
GlaxoSmithKline UK Ltd.
GlaxoSmithKline UK Ltd. Medical DistributorsDistribution Services Part of GSK Plc, GlaxoSmithKline UK Ltd. is a biopharma company that unites science, technology, and talent to get ahead of disease together. The company is based in Middlesex, UK and is focused on discovering and developing new products. The British company's portfolio includes vaccines, specialty, and general medicines. | Distribution Services |
GE Healthcare UK Ltd.
GE Healthcare UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Danaher Corp., Global Life Sciences Solutions Operations UK Ltd. is a company that engages in the manufacture of basic pharmaceutical products. The company is based in Little Chalfont, UK. Global Life Sciences Solutions Operations was founded in 1997. | Health Technology |
